🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Despite achieving an acceptable rate of use of adjuvant chemotherapy in non-elderly and medically fit stage III CRC patients recently, socioeconomic disparities impact its utilization, and avoiding/declining adjuvant chemotherapy leads to worse outcomes. authors.elsevier.com/a/1fymA5Sa88fI…

🎉⭐️Major implications for understanding CRC biology & rechallenge studies! Resistance Mechanisms to Anti-EGFR Therapy in RAS/RAF Wildtype Colorectal Cancer Vary by Regimen & Line of Therapy pubmed.ncbi.nlm.nih.gov/?term=36351210 ParseghianC DrJasonWillis VanMorrisMD skopetz MDAndersonNews

It's here and... waited for all embargoes to be lifted ... #neoadjuvant #melanoma SWOG Cancer Research Network #S1801 callback to ESMO - Eur. Oncology tag #neoadjuvanté 😉 A great team effort SWOG Cancer Research Network, @NCICTEP_ClinRes, NCTN, NCORPs - & ‼️ example of how cooperative groups can succeed! 💫 nejm.org/doi/full/10.10…

So excited to share our paper on MMR-proficient colorectal cancer in #LynchSyndrome, published today in JCO Precision Oncology! 🔬🧬☺️ #hereditaryGIcancers ✔️10% of CRC in LS were MMR-P ✔️3.7% of all LS pts had MMR-P CRC ✔️Most were in MSH6/PMS2+ individuals ascopubs.org/doi/abs/10.120…

Representing UTSW Simmons Cancer Center UTSW Hematology & Oncology Parkland Health at ASCO sharing how we can improve time toxicity for our underserved cancer patients

I am totally using this in clinic for my next patient. What about you Dr. Cathy Eng Kristen Ciombor Efrat Dotan MD Vanessa Wookey Michael J Hall Smitha Krishnamurthi Arvind Dasari, MD, MS Patrick Boland Suneel Kamath MD Syed Kazmi, M.D. Dustin Deming May Cho Pamela Kunz, MD, FASCO

Excited to announce that A022004 randomized trial of adjuvant encorafenib + cetuximab vs usual care after standard rx for BRAF V600E stage III, high risk stage II colon cancer is now activated and available to all NCTN sites. @Alliance_org Eileen M O’Reilly Smitha Krishnamurthi Syed Kazmi, M.D.

While adding ipilimumab to nivolumab didn’t move the needle forward like we hoped for our pts w/ met #analcancer , the drive to do better for #ancsm remains strong! Proud to be on National Cancer Institute #ETCTN team running large trials for rare cancers! #endcancer

Dr. Cathy Eng and I with this great cast of speakers. How do you make GI oncology fun and educational? Join #GDUGI2023 and see how.

🗞️Just published JCO Precision Oncology At the intersection of Liquid Biopsies🔄Precision Medicine Pan-cancer assessment of ✅PLASMA🩸MSI-High and assessment of real-world outcomes. 👉🏾1.4% of 171,881 patients. 💡If shed, 🧬#ctDNA MSI reliable. OncoAlert ASCO ascopubs.org/doi/full/10.12…

#ESMO23 Presidential session talk by Tom Powles 👉1st time in >30 years, a Rx regimen shows superiority to cisplatin based Rx in mUC #bladdercancer : Enfortumab + pembrolizumab combo vs platinum based Rx👉55% and 53% reduction in risk of progression and death with combo👇

Published today! 📰 Nature Medicine One of the first #cancer vaccines💉that target #KRAS. Not just G12C. 👇🏾The 2-peptide was G12D & R. The 7-Peptide/Elicio targets D R V S A C G13 ➕ NRAS Implications for so many patients! Open now. Cheers! OncoAlert nature.com/articles/s4159…

Learn "How to Build a Successful Phase I Clinical Trials Unit", with customized tips from Drs Razelle Kurzrock and David Hong. doi.org/10.36401/JIPO-… #phase1 #oncology MD Anderson Cancer Center Razelle Kurzrock, MD

Baqir Jafry did an excellent job presenting real-world data in pancreatic cancer under the guidance of one of our most promising young faculty, Dr. Tim Brown.

As ASCO winds down, I want to thank the late Dr. Waun Ki Hong for being an unbelievable mentor and supporter for so many who are now leading cancer breakthroughs. We were fortunate to have him cheering us on (then and now). MD Anderson Cancer Center cancerletter.com/in-the-archive…

Addition of Nintedenib to gem/abr was safe and well tolerated in a phase 1 trial of mPDAC. Congrats Salwan Al Mutar MD MS on the #ESMOGI24 presentation. Shaalan Beg MD MBA FASCO Syed Kazmi, M.D. Nilesh Verma

👋Join us 10/19-10/20 in #Dallas for Great Debates w/my co-Chair Yelena Y. Janjigian MD and 🤩faculty Michael Gibson, MD PhD Vanderbilt University. Nataliya Uboha Heather Hampel Michael J Hall Kristen Ciombor Smitha Krishnamurthi Rachna Shroff, MD, MS, FASCO Milind Javle Ghassan Abou-Alfa Arvind Dasari, MD, MS Hagen Kennecke Ardaman Shergill Prajnan Das, MD, MS, MPH

Thrilled to see ASCO guidelines recommending exercise for patients w/ cancer highlighted in the new The White House factsheet. Exercise during cancer treatment can improve cardiorespiratory fitness, strength, fatigue & may improve patient's quality of life.➡️ascopubs.org/doi/full/10.12…